- Home
- Companies
- Alcyomics Ltd.
- Products
- Skimune Mab - Human Based Skin Assay
Skimune Mab - Human Based Skin Assay
Alcyomics Skimune®Mab was developed to determine efficacy, potency, dose responses and detection of adverse immune responses to biologics, i.e. monoclonal antibodies (including their aggregated format), biosimilars and aptamers. It can be used as a valuable tool for pre-clinical testing by bridging the gap between animal testing and first-in-man studies; it facilitates the product profile to support clinical trials.
The human based skin assay, Skimune®Mab solves several problems of the use of animal models for safety testing such as:
- The selection of a relevant animal species,
- Disparity in safety responses related to interspecies differences,
- Effectiveness of safety responses of novel therapies tested in animals compared to humans.
We can provide our client with reliable and accurate data to remove risks associated with product development and help in the decision making process about product candidates during the drug development pipeline. The assay can be modified to client needs through our initial consultation service.
- Unique assay which uses human tissue
- Reducing the need for animals within the industry and provides more informative results compared to comparative animal models
- Early identification and elimination of problem compounds during the drug development pipeline
- Early identification of clinical failure due to adverse immune reactions
- All of the above saves you both time and money